NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $758,000 | -68.0% | 45,687 | -55.3% | 0.02% | -59.0% |
| Q2 2020 | $2,368,000 | +17.6% | 102,235 | -9.3% | 0.06% | +15.1% |
| Q1 2020 | $2,013,000 | -63.2% | 112,756 | -55.5% | 0.05% | -31.2% |
| Q4 2019 | $5,467,000 | +502.1% | 253,258 | +408.1% | 0.08% | +600.0% |
| Q3 2019 | $908,000 | +250.6% | 49,841 | +584.3% | 0.01% | +120.0% |
| Q2 2019 | $259,000 | +14.1% | 7,283 | +7.9% | 0.01% | 0.0% |
| Q1 2019 | $227,000 | -32.2% | 6,751 | -33.8% | 0.01% | -28.6% |
| Q4 2018 | $335,000 | -24.4% | 10,194 | +40.3% | 0.01% | -22.2% |
| Q3 2018 | $443,000 | +18.1% | 7,265 | -5.5% | 0.01% | -10.0% |
| Q2 2018 | $375,000 | -35.2% | 7,685 | +41.1% | 0.01% | -37.5% |
| Q1 2018 | $579,000 | – | 5,447 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |